Phoenix Biotech Acquisiti... (PBAXU)
NASDAQ: PBAXU
· Real-Time Price · USD
10.37
-0.01 (-0.10%)
At close: Feb 07, 2024, 3:37 PM
Phoenix Biotech Acquisition Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Cash & Equivalents | 5.2M | 3.33M | 3.38M | 3.65M | 119.01K | 105.23K | 178.09K | 475.87K | 507.92K | 553.77K | 790.48K | 1.1K | n/a | n/a |
Short-Term Investments | n/a | n/a | n/a | n/a | 8.33M | 13.9M | 14.03M | n/a | 179.64M | 178.79M | 178.5M | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 14.03M | n/a | 179.64M | 178.79M | 178.53M | 178.5K | n/a | n/a |
Other Long-Term Assets | 500K | 500K | n/a | n/a | n/a | n/a | n/a | n/a | 21.18K | 87.35K | 152.79K | 200.65 | 277K | 1K |
Receivables | n/a | n/a | n/a | 87.43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 564.46K | 386.98K | 334.28K | 511.46K | 21.82K | 107.98K | 220.29K | 225.19K | 277.38K | 292.25K | 307.13K | 262.50 | 24K | 24K |
Total Current Assets | 5.77M | 3.71M | 3.71M | 4.25M | 8.47M | 14.11M | 14.43M | 42.37M | 785.29K | 846.02K | 1.1M | 1.36K | 24K | 24K |
Property-Plant & Equipment | 1.72M | 1.99M | 3.21M | 3.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.22M | 2.49M | 2.78M | 3.12M | n/a | n/a | 14.03M | n/a | 179.67M | 178.88M | 178.68M | 178.72K | 277K | 1K |
Total Assets | 7.99M | 6.21M | 6.49M | 7.37M | 8.47M | 14.11M | 14.43M | 42.37M | 180.45M | 179.72M | 179.78M | 180.08K | 301K | 25K |
Account Payables | 6.38M | 4.51M | 6.67M | 6.35M | 3.31M | 3.15M | 2.02M | 1.65M | 710.36K | 163K | 121.34K | n/a | 1K | 1K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -4.32M | n/a | n/a | 21.18K | 87.35K | n/a | n/a | n/a | n/a |
Short-Term Debt | 905K | 876.39K | n/a | n/a | 1.4M | 1.18M | 650K | 650K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 575.16K | 2.02M | 2.76M | 2.43M | n/a | 90.03K | 626K | 28.45M | 165.61K | 71.2K | 53.31K | 98.07 | 276K | n/a |
Total Current Liabilities | 7.86M | 7.4M | 9.42M | 8.78M | 4.8M | 4.41M | 3.29M | 30.75M | 875.97K | 234.21K | 174.66K | 98.07 | 277K | 1K |
Long-Term Debt | 461.58K | 699.11K | 771.52K | 1.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 9.15M | 9.15M | 9.15M | 9.15M | 9.15M | 9.15M | 9.15M | 9.15K | n/a | n/a |
Total Long-Term Liabilities | 461.58K | 699.11K | 771.52K | 1.07M | 9.15M | 9.15M | 9.15M | 9.15M | 9.15M | 9.15M | 9.15M | 9.15K | n/a | n/a |
Total Liabilities | 8.32M | 8.1M | 10.19M | 9.85M | 13.95M | 13.56M | 12.44M | 39.9M | 10.03M | 9.38M | 9.32M | 9.25K | 277K | 1K |
Total Debt | 1.37M | 1.58M | 771.52K | 1.07M | 1.4M | 1.18M | 650K | 650K | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 86.02K | 85.74K | 14.75K | 2.27K | 8.29M | 13.84M | 13.57M | 13.22M | 179.48M | 178.5M | 178.5M | 178.5K | 467.00 | 468.00 |
Retained Earnings | -76.02M | -70.92M | -71.59M | -67.36M | -13.77M | -13.29M | -11.58M | -10.76M | -9.06M | -8.16M | -8.05M | -7.67K | -1K | -1K |
Comprehensive Income | n/a | n/a | n/a | n/a | 8.29M | 13.84M | 13.57M | 13.22M | 179.48M | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -329.39K | -1.89M | -3.7M | -2.48M | -5.48M | 549.25K | 1.99M | 2.47M | 170.43M | 170.34M | 170.45M | -7.67K | 24K | 24K |
Total Investments | n/a | n/a | n/a | n/a | 8.33M | 13.9M | 14.03M | n/a | 179.64M | 178.79M | 178.53M | 178.5K | n/a | n/a |